We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$69.2B
Turnover
15.26%
1-Year Est. Return
41.24%
This Quarter
Est. Return
+3.88%
1 Year Est. Return
+41.24%
3 Year Est. Return
+116.24%
5 Year Est. Return
+151.83%
10 Year Est. Return
+590.13%
AUM
$56.7B
AUM Growth
+$8.88B
(+19%)
Cap. Flow
+$7.92B
Cap. Flow
% of AUM
13.98%
Top 10 Holdings %
Top 10 Hldgs %
34.05%
Holding
2,107
New
102
Increased
1,467
Reduced
463
Closed
73
Avg Time Held
6
years
Top 10 Avg Time Held
5.7
years
Top 20 Avg Time Held
5.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$779M |
| 2 |
Apple
AAPL
|
+$539M |
| 3 |
Microsoft
MSFT
|
+$522M |
| 4 |
Meta Platforms (Facebook)
META
|
+$487M |
| 5 |
Tesla
TSLA
|
+$414M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$189M |
| 2 |
C.H. Robinson
CHRW
|
+$55.4M |
| 3 |
Fortinet
FTNT
|
+$55M |
| 4 |
AbbVie
ABBV
|
+$35.7M |
| 5 |
NextEra Energy
NEE
|
+$32.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.38% |
| 2 | Communication Services | 10.74% |
| 3 | Consumer Discretionary | 10.59% |
| 4 | Industrials | 8.58% |
| 5 | Consumer Staples | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1501
Trevi Therapeutics
TRVI
$1.73B
| $279K | ﹤0.01% |
22,269
+2,947
| +15% | +$34.1K |
2024 Q3
5 quarters
|
|
1502
DELISTED
Synovus
SNV
| $279K | ﹤0.01% |
5,566
-338
| -6% | -$16.2K |
2013 Q2
50 quarters
|
|
1503
Oruka Therapeutics
ORKA
$4.89B
| $279K | ﹤0.01% |
+9,189
| New | +$256K |
2025 Q4
0 quarters
|
|
1504
Xeris Biopharma Holdings
XERS
$1.84B
| $278K | ﹤0.01% |
35,390
+3,383
| +11% | +$26.6K |
2023 Q1
11 quarters
|
|
1505
Ziff Davis
ZD
$2B
| $277K | ﹤0.01% |
7,894
+42
| +0.5% | +$1.46K |
2013 Q2
50 quarters
|
|
1506
Aeluma Inc
ALMU
$171M
| $277K | ﹤0.01% |
+16,160
| New | +$255K |
2025 Q4
0 quarters
|
|
1507
DXP Enterprises
DXPE
$2.76B
| $277K | ﹤0.01% |
2,527
+82
| +3% | +$8.93K |
2024 Q4
4 quarters
|
|
1508
Triumph Financial Inc
TFIN
$1.48B
| $276K | ﹤0.01% |
4,414
+139
| +3% | +$7.79K |
2023 Q2
10 quarters
|
|
1509
Middleby
MIDD
$4.91B
| $276K | ﹤0.01% |
1,859
-124
| -6% | -$16.3K |
2020 Q2
22 quarters
|
|
1510
Murphy USA
MUSA
$10B
| $276K | ﹤0.01% |
684
-62
| -8% | -$23.8K |
2017 Q4
32 quarters
|
|
1511
Grab
GRAB
$12.3B
| $276K | ﹤0.01% |
55,301
+3,685
| +7% | +$20.4K |
2024 Q4
4 quarters
|
|
1512
NCR Voyix
VYX
$1.04B
| $276K | ﹤0.01% |
27,044
+844
| +3% | +$9.17K |
2024 Q3
5 quarters
|
|
1513
STAG Industrial
STAG
$6.88B
| $275K | ﹤0.01% |
7,489
-451
| -6% | -$17.1K |
2020 Q2
22 quarters
|
|
1514
The Greenbrier Companies
GBX
$1.22B
| $275K | ﹤0.01% |
5,889
+179
| +3% | +$8.03K |
2023 Q4
8 quarters
|
|
1515
Sally Beauty Holdings
SBH
$1.6B
| $275K | ﹤0.01% |
19,283
+260
| +1% | +$3.92K |
2023 Q1
11 quarters
|
|
1516
Post Holdings
POST
$3.51B
| $274K | ﹤0.01% |
2,771
-295
| -10% | -$30.5K |
2013 Q2
50 quarters
|
|
1517
Idacorp
IDA
$7.91B
| $274K | ﹤0.01% |
2,167
-131
| -6% | -$17K |
2013 Q2
50 quarters
|
|
1518
Pacira BioSciences
PCRX
$1.45B
| $273K | ﹤0.01% |
10,568
+315
| +3% | +$7.49K |
2013 Q2
50 quarters
|
|
1519
MP Materials
MP
$7.41B
| $273K | ﹤0.01% |
5,401
-323
| -6% | -$20.5K |
2025 Q3
1 quarter
|
|
1520
MasterBrand
MBC
$1.39B
| $273K | ﹤0.01% |
24,702
+767
| +3% | +$8.98K |
2023 Q2
10 quarters
|
|
1521
Albertsons Companies
ACI
$6.32B
| $272K | ﹤0.01% |
15,861
-1,284
| -7% | -$22.9K |
2025 Q1
3 quarters
|
|
1522
Blue Bird Corp
BLBD
$1.96B
| $272K | ﹤0.01% |
5,793
+372
| +7% | +$19.4K |
2024 Q2
6 quarters
|
|
1523
Nelnet
NNI
$4.58B
| $272K | ﹤0.01% |
2,047
-158
| -7% | -$20.7K |
2024 Q3
5 quarters
|
|
1524
Arlo Technologies
ARLO
$1.34B
| $272K | ﹤0.01% |
19,415
+592
| +3% | +$9.32K |
2020 Q2
22 quarters
|
|
1525
NETSTREIT Corp
NTST
$1.76B
| $271K | ﹤0.01% |
15,377
-853
| -5% | -$15.5K |
2024 Q3
5 quarters
|
|
Similar funds
ProShare Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, ProShare Advisors held 2,107 positions worth $56.7B, up 19% from $47.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
ProShare Advisors deployed $7.92B of net new capital in Q4 2025, opening 102 new positions and adding to 1,467 existing holdings. Its largest new stake was CRH: 131,018 shares worth $16.4M.
By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.
On the sell side, the largest reduction was Broadcom, an estimated $189M trimmed.
- ProShare Advisors's largest Q4 2025 buy was CRH: 131,018 shares worth $16.4M.
- ProShare Advisors added most to NVIDIA in Q4 2025, an estimated $779M increase.
- ProShare Advisors's biggest Q4 2025 reduction was Broadcom, cutting an estimated $189M.
- ProShare Advisors fully exited Perrigo in Q4 2025, selling an estimated $27.6M.
- ProShare Advisors's ten largest holdings make up 34% of its $56.7B portfolio in Q4 2025.
- ProShare Advisors opened 102 new positions and closed 73 in Q4 2025.
- ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $56.7B.
Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.